Brokerages forecast that HB Fuller Co (NYSE:FUL) will post sales of $784.75 million for the current quarter, Zacks reports. Four analysts have provided estimates for HB Fuller’s earnings, with the highest sales estimate coming in at $795.56 million and the lowest estimate coming in at $780.22 million. HB Fuller reported sales of $562.87 million in the same quarter last year, which indicates a positive year over year growth rate of 39.4%. The business is scheduled to issue its next quarterly earnings report on Wednesday, September 26th.
On average, analysts expect that HB Fuller will report full year sales of $3.12 billion for the current year, with estimates ranging from $3.09 billion to $3.16 billion. For the next financial year, analysts expect that the company will post sales of $3.25 billion per share, with estimates ranging from $3.18 billion to $3.29 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for HB Fuller.
HB Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, June 27th. The specialty chemicals company reported $0.89 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.86 by $0.03. The firm had revenue of $789.39 million during the quarter, compared to the consensus estimate of $808.06 million. HB Fuller had a net margin of 4.00% and a return on equity of 12.66%.
A number of analysts have issued reports on the stock. Zacks Investment Research raised shares of HB Fuller from a “hold” rating to a “buy” rating and set a $65.00 price objective for the company in a report on Wednesday, August 29th. Berenberg Bank assumed coverage on shares of HB Fuller in a report on Thursday, July 12th. They issued a “buy” rating and a $65.00 price objective for the company. Finally, JPMorgan Chase & Co. reissued an “overweight” rating and issued a $57.00 price objective on shares of HB Fuller in a report on Thursday, July 5th. Four analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. The company currently has an average rating of “Buy” and a consensus target price of $61.13.
NYSE FUL traded up $0.58 during trading on Thursday, reaching $56.45. The company’s stock had a trading volume of 569,200 shares, compared to its average volume of 399,109. The company has a quick ratio of 1.46, a current ratio of 2.24 and a debt-to-equity ratio of 2.07. The company has a market capitalization of $2.83 billion, a P/E ratio of 22.35, a P/E/G ratio of 0.91 and a beta of 1.48. HB Fuller has a 12 month low of $46.62 and a 12 month high of $59.58.
In other news, Director Sant R. William Van sold 5,500 shares of the business’s stock in a transaction that occurred on Friday, June 29th. The shares were sold at an average price of $54.12, for a total value of $297,660.00. Following the completion of the transaction, the director now directly owns 17,665 shares in the company, valued at approximately $956,029.80. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, VP Steven Kenny sold 2,200 shares of the business’s stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $56.19, for a total transaction of $123,618.00. Following the completion of the transaction, the vice president now owns 30,173 shares of the company’s stock, valued at $1,695,420.87. The disclosure for this sale can be found here. Insiders sold a total of 12,208 shares of company stock valued at $680,263 over the last 90 days. Corporate insiders own 3.46% of the company’s stock.
Several large investors have recently modified their holdings of FUL. BlackRock Inc. raised its position in shares of HB Fuller by 6.1% in the 2nd quarter. BlackRock Inc. now owns 7,233,376 shares of the specialty chemicals company’s stock valued at $388,286,000 after buying an additional 415,166 shares in the last quarter. Janus Henderson Group PLC increased its position in HB Fuller by 13.5% during the 2nd quarter. Janus Henderson Group PLC now owns 2,809,497 shares of the specialty chemicals company’s stock worth $150,814,000 after purchasing an additional 335,020 shares in the last quarter. New York State Common Retirement Fund increased its position in HB Fuller by 233.6% during the 1st quarter. New York State Common Retirement Fund now owns 216,528 shares of the specialty chemicals company’s stock worth $10,768,000 after purchasing an additional 151,615 shares in the last quarter. Champlain Investment Partners LLC increased its position in HB Fuller by 6.0% during the 1st quarter. Champlain Investment Partners LLC now owns 1,896,135 shares of the specialty chemicals company’s stock worth $94,295,000 after purchasing an additional 108,115 shares in the last quarter. Finally, Intrinsic Edge Capital Management LLC acquired a new position in HB Fuller during the 2nd quarter worth approximately $4,480,000. Institutional investors own 97.65% of the company’s stock.
About HB Fuller
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.